Moderna Inc. Stock Rises 6.8%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. advanced 6.8% to $242.27 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 26,424.82 and the Dow Jones Industrial Average rising 1.0% to 52,495.88.

This was the stock's second consecutive day of gains.

Moderna Inc. closed 0.0% below its 52-week high of $242.29, which the company achieved on October 15th.

The stock outperformed some of its peers, as Johnson & Johnson rose 2.2% to $259.36, Pfizer Inc. rose 2.3% to $30.11, and Gilead Sciences Inc. rose 2.27% to $156.54.

Trading volume totaled 16.7 million, compared to the 50-day average of 23.3 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 20, 2026 16:33 ET (20:33 GMT)